| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11025604 | Multiple Sclerosis and Related Disorders | 2018 | 22 Pages |
Abstract
There were no significant difference when comparing IFN β and teriflunomide in terms of liver failure or elevation of transaminases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Paola Andrea Ortiz Salas, Camila Olarte Parra, Carlos Eduardo Pinzon Florez, Lina Maria Goez, Alberto Velez-van-Meerbeke, Jesus Hernan Rodriguez,